Revolution Medicines (RVMD) Treasury Shares (2018 - 2026)
Revolution Medicines' quarterly Treasury Shares came in at $5.1 million in Q1 2026, up 33.82% year-on-year from $3.8 million in Q1 2025, and up 32.12% quarter-over-quarter from $3.9 million in Q4 2025.
Revolution Medicines has reported Treasury Shares for 9 years, with the latest figure at $5.1 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 33.82% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (up 33.82% YoY), and the FY2025 full-year result was $3.9 million, up 36.56% from the prior year.
- Treasury Shares for Q1 2026 stood at $5.1 million, up from $3.9 million in the prior quarter.
- The five-year high for Treasury Shares was $5.1 million in Q1 2026, with the low at $272.0 in Q4 2022.
- Average Treasury Shares over 5 years is $2.4 million, with a median of $2.9 million recorded in 2024.
- Year-over-year, Treasury Shares plunged 99.97% in 2023 and jumped 1102504.81% in 2024.
- Tracing RVMD's Treasury Shares over 5 years: stood at $272.0 in 2022, then advanced by 6.99% to $291.0 in 2023, then surged by 979319.93% to $2.9 million in 2024, then soared by 36.56% to $3.9 million in 2025, then surged by 32.12% to $5.1 million in 2026.
- The last three Treasury Shares figures came in at $5.1 million (Q1 2026), $3.9 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 5.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.14 Mn |
| Mar 31, 2026 | 5.14 Mn |
| Dec 31, 2025 | 3.89 Mn |
| Dec 31, 2025 | 3.89 Mn |
| Sep 30, 2025 | 3.84 Mn |
| Sep 30, 2025 | 3.84 Mn |
| Jun 30, 2025 | 3.81 Mn |
| Jun 30, 2025 | 3.81 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Sep 30, 2024 | 2.97 Mn |
| Sep 30, 2024 | 2.97 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 3.21 Mn |
| Mar 31, 2024 | 3.21 Mn |
| Dec 31, 2023 | 291.00 |
| Dec 31, 2023 | 291.00 |
| Sep 30, 2023 | 2.09 Mn |
| Sep 30, 2023 | 2.09 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Mar 31, 2023 | 291.00 |
| Mar 31, 2023 | 291.00 |
| Dec 31, 2022 | 272.00 |
| Dec 31, 2022 | 272.00 |
| Sep 30, 2022 | 1.19 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.15 Mn |
| Mar 31, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 5,793.00 |
| Dec 31, 2021 | 5,793.00 |
| Sep 30, 2021 | 406,374.00 |
| Sep 30, 2021 | 406,374.00 |
| Jun 30, 2021 | 383,768.00 |
| Jun 30, 2021 | 383,768.00 |
| Mar 31, 2021 | 352,332.00 |
| Mar 31, 2021 | 352,332.00 |
| Dec 31, 2020 | 18,158.00 |
| Dec 31, 2020 | 18,158.00 |
| Sep 30, 2020 | 67,260.00 |
| Sep 30, 2020 | 67,260.00 |
| Jun 30, 2020 | 48,660.00 |
| Jun 30, 2020 | 48,660.00 |
| Dec 31, 2019 | 87,910.00 |
| Dec 31, 2019 | 87,910.00 |
| Sep 30, 2019 | 24,740.00 |
| Sep 30, 2019 | 24,740.00 |
| Jun 30, 2019 | 51,375.00 |
| Jun 30, 2019 | 51,375.00 |
| Mar 31, 2019 | 1,948.00 |
| Mar 31, 2019 | 1,948.00 |
| Dec 31, 2018 | 118,700.00 |
| Dec 31, 2018 | 118,700.00 |